Marcin Pieklak is an attorney admitted to practice in Poland, a partner in the corporate department of Rymarz Zdort Maruta and co-head of the Life Sciences practice.
He has many years of experience in the healthcare sector, and is an expert in pharmaceutical law, food law and contract law. He specialises, among others, in reimbursement proceedings, the financing of guaranteed services and tenders.
His experience includes representing clients before health authorities, including the Minister of Health, the Chief Pharmaceutical Inspector, the Chief Health Inspector and the Chairman of the National Health Fund. He has advised on numerous reimbursement proceedings that resulted in the financing of new, innovative medicines, foodstuffs and medical devices. His extensive knowledge of the legal system and market conditions allows him to support clients from the very first stages of a process, including in connection with early access and emergency treatment programmes.
He has experience working on the side of public payers, on behalf of which he has advised in connection with reimbursement proceedings, appeared before administrative courts and co-developed a reimbursement policy. He is the author of the most comprehensive study on the reimbursement market. He also provides ongoing advice to companies in the Life Sciences sector, including pharmaceutical and food companies.
His previous work in regulatory bodies has given him insight that has proven invaluable when it comes to advising on the marketing, advertising and promotion of products. His experience in the field of contracts based on general contract law has enabled him to provide services to multinational corporations in respect of cross-border matters. He graduated from the Faculty of Law and Administration at the University of Warsaw in 2010 and from the Faculty of Journalism and Political Science in 2012, and received a Bachelor’s Degree in Pharmacoeconomics from the Business School of the Warsaw University of Technology in 2014. He was admitted to the bar in 2015.
In the prestigious ranking of Chambers and Partners Europe, he was recognised in the Life Sciences field in the “Up and Coming” category. He advises national and international pharmaceutical companies in many areas, with a particular focus on reimbursement issues.
The Legal 500 has named Marcin Pieklak as a “next generation partner” in the Healthcare and Life Sciences area with extensive expertise in the registration and reimbursement of medicinal products.
In 2023, he was named a Non-IP Litigation Rising Star in the LMG Life Sciences EMEA Awards.
15 April 2024
We are pleased to announce that Rymarz Zdort Maruta advised Mycofeast LTD on the acquisition of the Leżajsk Brewery from Grupa Żywiec sp. z o.o. The preliminary conditional investment and share p...